This Department of Defense (DoD) grant, the Ovarian Cancer Synergistic Translational Leverage Award, is designed to facilitate partnerships between two Principal Investigators. Its primary purpose is to leverage existing human-based ovarian cancer resources for high-impact translational research and to address unmet needs in the field. By encouraging the sharing and maximal use of valuable, often underutilized resources like biorepositories, tissue banks, epidemiological resources, and large datasets, this initiative aims to avoid costly duplication of effort and optimize the use of expensive, pre-existing resources, ultimately advancing critical ovarian cancer research.
Opportunity ID: 146754
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-12-OCRP-STLA |
| Funding Opportunity Title: | DoD Ovarian Cancer Synergistic Translational Leverage Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 5 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Feb 27, 2012 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Jul 18, 2012 |
| Current Closing Date for Applications: | Jul 18, 2012 |
| Archive Date: | Aug 17, 2012 |
| Estimated Total Program Funding: | $3,750,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | The OCRP Synergistic Translational Leverage Award mechanism supports the partnership between two Principal Investigators (PIs; termed “partners”) who will leverage existing human-based ovarian cancer resources in translational research to address high-impact research ideas or unmet needs in ovarian cancer. Many ovarian cancer resources are confined to investigators’ labs where they were first developed and are not always available for use by others. Often, resources are not leveraged for maximum use beyond the original source, and as a result, investigators expend time and money to duplicate those resources. These existing resources are expensive to generate, maintain, and make available to other investigators, but they may have broad applicability across many different types of research questions. Examples of human-based resources include, but are not limited to, biorepositories of clinical specimens, existing tissue banks, epidemiological resources, clinical databases, large transcriptome or proteome datasets, and databases of clinical data and/or metadata. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
301-682-5507; help@cdmrp.org
Email:help@cdmrp.org |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 146754 Full Announcement-1 -> ocrp_fy12 stla_ gg.pdf
Packages
| Agency Contact Information: | 301-682-5507; help@cdmrp.org Email: help@cdmrp.org |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 12.420 | PKG00099993 | Feb 27, 2012 | Jul 18, 2012 | View |
Package 1
Mandatory forms
146754 RR_SF424_1_2-1.2.pdf
146754 PerformanceSite_1_4-1.4.pdf
146754 RR_Budget-1.1.pdf
Optional forms
146754 RR_SubawardBudget30-1.2.pdf
146754 RR_KeyPersonExpanded_1_2-1.2.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
